Unique physicochemical profile of beta-amyloid peptide variant Abeta1-40E22G protofibrils: conceivable neuropathogen in arctic mutant carriers - PubMed (original) (raw)
Comparative Study
. 2004 May 21;339(1):145-59.
doi: 10.1016/j.jmb.2004.03.028.
Affiliations
- PMID: 15123427
- DOI: 10.1016/j.jmb.2004.03.028
Comparative Study
Unique physicochemical profile of beta-amyloid peptide variant Abeta1-40E22G protofibrils: conceivable neuropathogen in arctic mutant carriers
A Päiviö et al. J Mol Biol. 2004.
Abstract
A new early-onset form of Alzheimer's disease (AD) was described recently where a point mutation was discovered in codon 693 of the beta-amyloid (Abeta) precursor protein gene, the Arctic mutation. The mutation translates into a single amino acid substitution, glutamic acid-->glycine, in position 22 of the Abeta peptide. The mutation carriers have lower plasma levels of Abeta than normal, while in vitro studies show that Abeta1-40E22G protofibril formation is significantly enhanced. We have explored the nature of the Abeta1-40E22G peptide in more detail, in particular the protofibrils. Using size-exclusion chromatography (SEC) and circular dichroism spectroscopy (CD) kinetic and secondary structural characteristics were compared with other Abeta1-40 peptides and the Abeta12-28 fragment, all having single amino acid substitutions in position 22. We have found that Abeta1-40E22G protofibrils are a group of comparatively stabile beta-sheet-containing oligomers with a heterogeneous size distribution, ranging from >100 kDa to >3000 kDa. Small Abeta1-40E22G protofibrils are generated about 400 times faster than large ones. Salt promotes their formation, which significantly exceeds all the other peptides studied here, including the Dutch mutation Abeta1-40E22Q. Position 22 substitutions had significant effects on aggregation kinetics of Abeta1-40 and in Abeta12-28, although the qualitative aspects of the effects differed between the native peptide and the fragment, as no protofibrils were formed by the fragments. The rank order of protofibril formation of Abeta1-40 and its variants was the same as the rank order of the length of the nucleation/lag phase of the Abeta12-28 fragments, E22V>E22A?E22G>E22Q?E22, and correlated with the degree of hydrophobicity of the position 22 substituent. The molecular mass of peptide monomers and protofibrils were estimated better in SEC studies using linear rather than globular calibration standards. The characteristics of the Abeta1-40E22G suggest an important role for the peptide in the neuropathogenesis in the Arctic form of AD.
Similar articles
- The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.
Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, Stenh C, Luthman J, Teplow DB, Younkin SG, Näslund J, Lannfelt L. Nilsberth C, et al. Nat Neurosci. 2001 Sep;4(9):887-93. doi: 10.1038/nn0901-887. Nat Neurosci. 2001. PMID: 11528419 - Physiochemical characterization of the Alzheimer's disease-related peptides A beta 1-42Arctic and A beta 1-42wt.
Johansson AS, Berglind-Dehlin F, Karlsson G, Edwards K, Gellerfors P, Lannfelt L. Johansson AS, et al. FEBS J. 2006 Jun;273(12):2618-30. doi: 10.1111/j.1742-4658.2006.05263.x. FEBS J. 2006. PMID: 16817891 - Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity.
Wilhelmus MM, Boelens WC, Otte-Höller I, Kamps B, de Waal RM, Verbeek MM. Wilhelmus MM, et al. Brain Res. 2006 May 17;1089(1):67-78. doi: 10.1016/j.brainres.2006.03.058. Epub 2006 Apr 24. Brain Res. 2006. PMID: 16635482 - Amyloid-beta aggregates formed at polar-nonpolar interfaces differ from amyloid-beta protofibrils produced in aqueous buffers.
Nichols MR, Moss MA, Reed DK, Hoh JH, Rosenberry TL. Nichols MR, et al. Microsc Res Tech. 2005 Jul;67(3-4):164-74. doi: 10.1002/jemt.20189. Microsc Res Tech. 2005. PMID: 16103999 Review. - Amyloid-beta aggregation.
Finder VH, Glockshuber R. Finder VH, et al. Neurodegener Dis. 2007;4(1):13-27. doi: 10.1159/000100355. Neurodegener Dis. 2007. PMID: 17429215 Review.
Cited by
- Alzheimer's Disease and Its Possible Evolutionary Origin: Hypothesis.
Whitfield JF, Rennie K, Chakravarthy B. Whitfield JF, et al. Cells. 2023 Jun 13;12(12):1618. doi: 10.3390/cells12121618. Cells. 2023. PMID: 37371088 Free PMC article. Review. - Differential effects of familial Alzheimer's disease-causing mutations on amyloid precursor protein (APP) trafficking, proteolytic conversion, and synaptogenic activity.
Schilling S, Pradhan A, Heesch A, Helbig A, Blennow K, Koch C, Bertgen L, Koo EH, Brinkmalm G, Zetterberg H, Kins S, Eggert S. Schilling S, et al. Acta Neuropathol Commun. 2023 Jun 1;11(1):87. doi: 10.1186/s40478-023-01577-y. Acta Neuropathol Commun. 2023. PMID: 37259128 Free PMC article. - Impact of Mutations on the Conformational Transition from α-Helix to β-Sheet Structures in Arctic-Type Aβ40: Insights from Molecular Dynamics Simulations.
Saini RK, Shuaib S, Goyal D, Goyal B. Saini RK, et al. ACS Omega. 2020 Aug 28;5(36):23219-23228. doi: 10.1021/acsomega.0c02983. eCollection 2020 Sep 15. ACS Omega. 2020. PMID: 32954172 Free PMC article. - Conformational Characterization of Native and L17A/F19A-Substituted Dutch-Type β-Amyloid Peptides.
He KC, Chen YR, Liang CT, Huang SJ, Tzeng CY, Chang CF, Huang SJ, Huang HB, Lin TH. He KC, et al. Int J Mol Sci. 2020 Apr 7;21(7):2571. doi: 10.3390/ijms21072571. Int J Mol Sci. 2020. PMID: 32272787 Free PMC article. - Thermodynamics of Amyloid-β Fibril Elongation: Atomistic Details of the Transition State.
Rodriguez RA, Chen LY, Plascencia-Villa G, Perry G. Rodriguez RA, et al. ACS Chem Neurosci. 2018 Apr 18;9(4):783-789. doi: 10.1021/acschemneuro.7b00409. Epub 2017 Dec 27. ACS Chem Neurosci. 2018. PMID: 29239603 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials